St. Jude Medical

St. Jude Medical was a leading global medical device manufacturer focused on developing innovative technologies for cardiovascular and neurological conditions. The company specialized in cardiac rhythm management, heart failure, atrial fibrillation, vascular health, and neuromodulation. Its extensive product portfolio included pacemakers, implantable cardioverter defibrillators (ICDs), mechanical heart valves, and spinal cord stimulators. In January 2017, the company was acquired by Abbott Laboratories for approximately $25 billion. This acquisition integrated St. Jude's strong positions in heart failure and atrial fibrillation with Abbott's existing cardiovascular leadership.